Trump's Health Pick: What It Means for Patients and Drugmakers

Donald Trump has hinted that Robert F. Kennedy Jr. , a notable vaccine skeptic, might play a significant role in his administration's health policies if he wins the presidency. This decision is causing concern among health experts. Some fear that it could lead to lower vaccination rates, an increase in preventable diseases, and more distrust in federal health agencies. Kennedy, who lacks medical or scientific credentials, believes drug companies are harming Americans. He's suggested taking certain vaccines off the market, a view Trump hasn't ruled out.

Experts worry that Kennedy could politicize treatments and spread misinformation, which could impact patients and drugmakers alike. The pharmaceutical industry relies on federal agencies to approve and fund their products. While Kennedy might not drastically change the approval process, he could influence federal funding and advisory panels, potentially leading to less reliable health recommendations. His anti-vaccine stance could also deter people from getting vaccinated, which could be particularly harmful during a pandemic.

Actions